Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.

A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Abstract Text:

    bettina s nedergaardBettina S Nedergaard,morten ladekarlMorten Ladekarl,jens randel nyengaardJens Randel Nyengaard,karsten nielsenKarsten Nielsen,bettina s nedergaardBettina S Nedergaard,morten ladekarlMorten Ladekarl,jens randel nyengaardJens Randel Nyengaard,karsten nielsenKarsten Nielsen,bettina s nedergaardBettina S Nedergaard,morten ladekarlMorten Ladekarl,jens randel nyengaardJens Randel Nyengaard,karsten nielsenKarsten Nielsen,

    OBJECTIVE: The purpose of this study was to investigate possible differences in the primary in situ cellular immune response between patients with and without relapse of Stage IB cervical squamous cell carcinoma. METHOD: Paraffin-embedded tissue from 40 patients (20 with and 20 without relapse) was evaluated. Sections were immunostained for CD1a(+), CD3(+), CD4(+), CD8(+), CD20(+), CD45RA(+), CD45RO(+), CD57(+), CD68(+) and GrB(+) cells. Immune cell profile densities were estimated using stereology. RESULTS: We found significantly lower densities of CD3(+), CD4(+), CD8(+) and CD57(+) cells (both intra- and peritumoral) in tissue from patients who had relapse. Also densities of intratumoral CD1a(+) cells and peritumoral CD20(+), CD45RA(+) and CD45RO(+) cells were significantly lower among patients with relapse. CONCLUSION: This study demonstrates striking differences in the cellular immune response between patients with and without relapse within 5 years. The results are of potential value in adjuvant immunotherapy and prediction of prognosis.

    A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Publishing Authors By Initials

    bs nedergaardBS Nedergaard,m ladekarlM Ladekarl,jr nyengaardJR Nyengaard,k nielsenK Nielsen,bs nedergaardBS Nedergaard,m ladekarlM Ladekarl,jr nyengaardJR Nyengaard,k nielsenK Nielsen,bs nedergaardBS Nedergaard,m ladekarlM Ladekarl,jr nyengaardJR Nyengaard,k nielsenK Nielsen,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Gynecologic oncology

    VOLUME: 108

    Page Numbers: 106-11

    Journal Abbreviation: Gynecol. Oncol.

    ISSN: 1095-6859

    DAY: 22

    MONTH: 10

    YEAR: 2007

    A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 365304

    A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.

    AFFILIATION: Department of Oncology, Aalborg Hospital, Aarhus University Hospital, Denmark.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Gynecol Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News